Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' Input – ValueWalk Premium

Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' Input

Daniel Loeb's hedge fund, Third Point LLC, might think its latest investment, Amgen, Inc. (NASDAQ:AMGN), has a multiple investment personality disorder.
Loeb divides Amgen into two distinct companies
In a letter to investors Loeb recommended the company be divided into two distinct companies: one a fast growing growth company, well suited for the active, momentum traders; and a second company, the mature growth company, that delivered solid dividends to shareholders.

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0